Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 9 studies | 40% ± 21% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 27% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 99% | 331.01 | 961 / 966 | 98% | 4.34 | 517 / 527 |
esophagus | 97% | 338.35 | 1407 / 1445 | 100% | 7.47 | 183 / 183 |
lung | 98% | 242.62 | 567 / 578 | 99% | 6.03 | 1140 / 1155 |
uterus | 96% | 237.50 | 163 / 170 | 98% | 7.99 | 450 / 459 |
prostate | 98% | 242.42 | 239 / 245 | 92% | 2.25 | 464 / 502 |
thymus | 98% | 193.40 | 640 / 653 | 92% | 3.29 | 556 / 605 |
stomach | 90% | 181.53 | 323 / 359 | 98% | 4.45 | 280 / 286 |
ovary | 90% | 160.90 | 162 / 180 | 98% | 6.18 | 420 / 430 |
bladder | 86% | 206.71 | 18 / 21 | 98% | 4.83 | 494 / 504 |
pancreas | 69% | 92.56 | 227 / 328 | 97% | 4.04 | 172 / 178 |
breast | 65% | 97.25 | 297 / 459 | 100% | 6.14 | 1113 / 1118 |
skin | 100% | 702.77 | 1800 / 1809 | 59% | 1.42 | 280 / 472 |
kidney | 73% | 135.43 | 65 / 89 | 81% | 2.15 | 726 / 901 |
brain | 90% | 489.40 | 2373 / 2642 | 60% | 1.77 | 426 / 705 |
adrenal gland | 64% | 76.16 | 164 / 258 | 66% | 1.42 | 151 / 230 |
lymph node | 0% | 0 | 0 / 0 | 100% | 7.04 | 29 / 29 |
spleen | 100% | 658.54 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 10.56 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.54 | 1 / 1 |
blood vessel | 85% | 206.36 | 1138 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 68% | 549.35 | 636 / 929 | 0% | 0 | 0 / 0 |
adipose | 49% | 64.24 | 587 / 1204 | 0% | 0 | 0 / 0 |
liver | 15% | 17.10 | 35 / 226 | 33% | 0.78 | 132 / 406 |
eye | 0% | 0 | 0 / 0 | 15% | 0.18 | 12 / 80 |
heart | 11% | 12.58 | 93 / 861 | 0% | 0 | 0 / 0 |
muscle | 2% | 1.80 | 15 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0046597 | Biological process | negative regulation of viral entry into host cell |
GO_0043124 | Biological process | negative regulation of canonical NF-kappaB signal transduction |
GO_0045087 | Biological process | innate immune response |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0030992 | Cellular component | intraciliary transport particle B |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | TRIM59 |
Protein name | Tripartite motif containing 59 Tripartite motif-containing protein 59 (EC 2.3.2.27) (RING finger protein 104) (Tumor suppressor TSBF-1) |
Synonyms | TRIM57 RNF104 TSBF1 |
Description | FUNCTION: E3 ubiquitin ligase involved in different processes such as development and immune response . Serves as a negative regulator for innate immune signaling pathways by suppressing RLR-induced activation of IRF3/7 and NF-kappa-B via interaction with adapter ECSIT . Regulates autophagy through modulating both the transcription and the ubiquitination of BECN1 . On the one hand, regulates the transcription of BECN1 through negatively modulating the NF-kappa-B pathway. On the other hand, regulates TRAF6-mediated 'Lys-63'-linked ubiquitination of BECN1, thus affecting the formation of the BECN1-PIK3C3 complex. In addition, mediates 'Lys-48'-linked ubiquitination of TRAF6 and thereby promotes TRAF6 proteasomal degradation . Acts also as a critical regulator for early embryo development from blastocyst stage to gastrula through modulating F-actin assembly and WASH1 'Lys-63'-linked ubiquitination (By similarity). . |
Accessions | ENST00000496222.1 ENST00000543469.1 ENST00000471155.5 C9IZE0 ENST00000468542.1 ENST00000309784.9 [Q8IWR1-1] C9JNB9 C9J9F0 C9IY67 ENST00000494486.1 F5GZP3 C9JE08 Q8IWR1 ENST00000471396.1 C9J614 ENST00000479460.5 |